Hyper-reflective foci changes in RRMS under natalizumab therapy.
Puthenparampil M, Basili E, Ponzano M, Mauceri VA, Miscioscia A, Pilotto E, Perini P, Rinaldi F, Bovis F, Gallo P.
Puthenparampil M, et al. Among authors: rinaldi f.
Front Immunol. 2024 Jul 15;15:1421755. doi: 10.3389/fimmu.2024.1421755. eCollection 2024.
Front Immunol. 2024.
PMID: 39076978
Free PMC article.